Related references
Note: Only part of the references are listed.Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality
Nicolas Richard et al.
RHEUMATOLOGY (2019)
Intravenous immunoglobulin in drug and device refractory patients with the symptoms of gastroparesisan open-label study
M. Ashat et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Gastrointestinal involvement in systemic sclerosis: diagnosis and management
Zsuzsanna H. McMahan et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis
Daniel E. Furst et al.
RHEUMATOLOGY (2017)
Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification
N. Aggarwal et al.
DISEASES OF THE ESOPHAGUS (2017)
Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature
Sebastien Sanges et al.
AUTOIMMUNITY REVIEWS (2017)
Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis
S. Kumar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis
Jasmin Raja et al.
RHEUMATOLOGY (2016)
Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG
Sumit Kumar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Current management of the gastrointestinal complications of systemic sclerosis
Anton Emmanuel
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility
E. P. Flanagan et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Effects of Scleroderma Antibodies and Pooled Human Immunoglobulin on Anal Sphincter and Colonic Smooth Muscle Function
Jagmohan Singh et al.
GASTROENTEROLOGY (2012)
Gastrointestinal Manifestations of Scleroderma: Recent Progress in Evaluation, Pathogenesis, and Management
Genevieve Gyger et al.
CURRENT RHEUMATOLOGY REPORTS (2012)
Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility
Y. Kawaguchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission
D Cavill et al.
ARTHRITIS AND RHEUMATISM (2003)
Antibody-mediated gastrointestinal dysmotility in scleroderma
F Goldblatt et al.
GASTROENTEROLOGY (2002)
Share Paper
